Nanobiotix is trading 5.35% up at $31.29 in pre-market on November 5, 2026, in line with a positive biotech-sector backdrop.
- Shares closed at $29.70 on November 4. No new company-specific announcement was found for November 5; the latest company release located was October 24.
- XBI was up 2.08% pre-market, amid attention on strong Amgen results and outlook. Amgen reported a third-quarter earnings beat and raised its 2026 guidance.
- No volume information was provided.